Used for: Lowering the risk of infection during chemotherapy · Faster white blood cell recovery in leukemia (AML) treatment · Faster white blood cell recovery after a bone marrow transplant · Collecting your own stem cells from the blood · Low white blood cells from birth, cyclic or unexplained · 4 more
How to pay the least
Ask for the cash price
Nivestym
Nivestym is a biologic. Biologics don’t have generics, but some have biosimilars or an unbranded version from the same maker. Ask your pharmacist or prescriber whether one is sold.
What to do
Ask your pharmacy for Nivestym’s cash price, and one or two other pharmacies too.
Nivestym’s savings card works only with insurance from a job or one you bought.
Compare every option
Brand name
Nivestym, the original
Cash priceAsk the pharmacy
Ways to save on Nivestym
The maker’s card
Pfizer Oncology Together Co-Pay Savings Program for Injectables
Savings card from Pfizer
No insuranceNeeds insuranceNo cash price listed.
Insurance · as little as$0a dose
The card takes up to $4,000–$10,000 a year off your co-pay.
From the maker’s offer on pfizercopay.com, checked November 17, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.
Maker’s card or discount card?
A discount card like GoodRx lowers the pharmacy’s cash price, but for a brand-name drug that price often stays high. Compare it with the maker’s card above. You can usually use one or the other on a fill, not both.
Authorized generic
There isn’t one.
Not soldThere isn’t one
Regular generic
Nivestym is a biologic. Biologics don’t have generics, but some have biosimilars or an unbranded version from the same maker. Ask your pharmacist or prescriber whether one is sold.
Not soldAsk the pharmacy
What it’s used for
Lowering the risk of infection during chemotherapy
Faster white blood cell recovery in leukemia (AML) treatment
NIVESTYM is a leukocyte growth factor indicated to
Decrease the incidence of infection‚ as manifested by febrile neutropenia‚ in patients with nonmyeloid malignancies receiving myelosuppressive anti-cancer drugs associated with a significant incidence of severe neutropenia with fever.
Reduce the time to neutrophil recovery and the duration of fever, following induction or consolidation chemotherapy treatment of patients with acute myeloid leukemia (AML).
Reduce the duration of neutropenia and neutropenia-related clinical sequelae‚ e.g.‚ febrile neutropenia, in patients with nonmyeloid malignancies undergoing myeloablative chemotherapy followed by bone marrow transplantation (BMT).
Mobilize autologous hematopoietic progenitor cells into the peripheral blood for collection by leukapheresis.
Reduce the incidence and duration of sequelae of severe neutropenia (e.g.‚ fever‚ infections‚ oropharyngeal ulcers) in symptomatic patients with congenital neutropenia‚ cyclic neutropenia‚ or idiopathic neutropenia.
Source: the FDA label for Nivestym (Pfizer Laboratories Div Pfizer Inc), August 12, 2025. Full label on DailyMed
Good to know
“Commercial insurance” means a plan from a job, from the marketplace, or one you buy yourself. A retiree plan that’s part of Medicare counts as Medicare. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.
Most cards need a sign-up on the maker’s site, and many work only if your plan covers the drug. Then give the card’s details to your pharmacy.
Don’t stop or change a medicine without talking to your pharmacist or prescriber.
Prices checked November 17, 2026. Prices change: confirm with the pharmacy before you fill. drugalt.com/drug/nivestym/